MX2016012641A - Dispersiones solidas secas en aceite en agua por aspersion para inhalacion de ingredientes farmaceuticos activos. - Google Patents

Dispersiones solidas secas en aceite en agua por aspersion para inhalacion de ingredientes farmaceuticos activos.

Info

Publication number
MX2016012641A
MX2016012641A MX2016012641A MX2016012641A MX2016012641A MX 2016012641 A MX2016012641 A MX 2016012641A MX 2016012641 A MX2016012641 A MX 2016012641A MX 2016012641 A MX2016012641 A MX 2016012641A MX 2016012641 A MX2016012641 A MX 2016012641A
Authority
MX
Mexico
Prior art keywords
inhalation
spray
oil
active pharmaceutical
particles
Prior art date
Application number
MX2016012641A
Other languages
English (en)
Inventor
Weers Jeffry
Huang Daniel
Miller Danforth
Rao Nagaraja
Tan Trixie
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2016012641A publication Critical patent/MX2016012641A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Las modalidades de la invención se refieren a agentes particulados y composiciones que comprenden agentes particulados para inhalación, y métodos para preparar dichos agentes particulados y composiciones para inhalación, así como métodos terapéuticos. Las modalidades del método comprenden la preparación de una emulsión al combinar una dispersión en fase de aceite de partículas semilla hidrófobas y una dispersión acuosa, que comprende un emulsificante y un estabilizador de emulsión, y preparar una carga de alimentación que comprende partículas encapsuladas homogeneizando la emulsión y formando una pluralidad de partículas recubiertas mediante secado por aspersión de la carga de alimentación, donde las partículas resultantes comprenden una cubierta porosa dispuesta en o sobre un núcleo, el cual comprende al menos una partícula semilla hidrófoba.
MX2016012641A 2014-03-27 2015-03-24 Dispersiones solidas secas en aceite en agua por aspersion para inhalacion de ingredientes farmaceuticos activos. MX2016012641A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461971232P 2014-03-27 2014-03-27
PCT/IB2015/052151 WO2015145353A1 (en) 2014-03-27 2015-03-24 Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients

Publications (1)

Publication Number Publication Date
MX2016012641A true MX2016012641A (es) 2016-12-14

Family

ID=52808092

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012641A MX2016012641A (es) 2014-03-27 2015-03-24 Dispersiones solidas secas en aceite en agua por aspersion para inhalacion de ingredientes farmaceuticos activos.

Country Status (10)

Country Link
US (1) US10744098B2 (es)
EP (1) EP3122331A1 (es)
JP (1) JP2017508776A (es)
KR (1) KR20160137543A (es)
CN (1) CN106102724A (es)
AU (1) AU2015237857B2 (es)
CA (1) CA2940599A1 (es)
MX (1) MX2016012641A (es)
RU (1) RU2016141948A (es)
WO (1) WO2015145353A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE058207T2 (hu) 2017-01-31 2022-07-28 Veru Inc Készítmények és módszerek gonadotropin felszabadító hormon (GNRH) antagonisták elnyújtott idejû felszabadítására
US20200197311A1 (en) * 2017-06-12 2020-06-25 Novartis Ag Amorphous nanostructured pharmaceutical materials
MX2018007248A (es) 2018-06-14 2019-12-16 Centro De Investigacion En Quim Aplicada Método de obtención de partículas porosas mediante un proceso híbrido de pulverización por secado-enfriamiento.
JP7404671B2 (ja) * 2019-06-25 2023-12-26 株式会社リコー 多孔質微粒子及びその製造方法、並びに医薬組成物
CN116421585A (zh) * 2023-05-09 2023-07-14 苏州欧米尼医药有限公司 一种混悬型布地奈德吸入气雾剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
ATE8790T1 (de) 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US6010935A (en) 1997-08-21 2000-01-04 Micron Technology, Inc. Self aligned contacts
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
WO2001085136A2 (en) * 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
ES2337252T3 (es) * 2000-10-13 2010-04-22 Nova Bio-Pharma Technologies Limited Suspensiones liquidas farmaceuticas.
PL1610850T3 (pl) 2003-04-09 2012-11-30 Novartis Ag Urządzenie rozpylające z osłoną wlotu powietrza
GB0410712D0 (en) 2004-05-13 2004-06-16 Novartis Ag Organic compounds
GB0413960D0 (en) 2004-06-22 2004-07-28 Novartis Ag Organic compounds
AU2007309412B2 (en) 2006-10-25 2011-10-20 Novartis Ag Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
BRPI0811562A2 (pt) 2007-05-07 2014-12-09 Novartis Ag Compostos orgânicos
CA2762179A1 (en) * 2009-05-18 2010-11-25 Sigmoid Pharma Limited Composition comprising oil drops
JOP20120023B1 (ar) * 2011-02-04 2022-03-14 Novartis Ag صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
US9452139B2 (en) * 2013-03-14 2016-09-27 Novartis Ag Respirable agglomerates of porous carrier particles and micronized drug

Also Published As

Publication number Publication date
US20170007547A1 (en) 2017-01-12
AU2015237857B2 (en) 2017-08-10
KR20160137543A (ko) 2016-11-30
EP3122331A1 (en) 2017-02-01
CA2940599A1 (en) 2015-10-01
US10744098B2 (en) 2020-08-18
CN106102724A (zh) 2016-11-09
JP2017508776A (ja) 2017-03-30
AU2015237857A1 (en) 2016-09-01
WO2015145353A1 (en) 2015-10-01
RU2016141948A (ru) 2018-04-27

Similar Documents

Publication Publication Date Title
MX2016012641A (es) Dispersiones solidas secas en aceite en agua por aspersion para inhalacion de ingredientes farmaceuticos activos.
WO2016098910A8 (en) Composite particle and preparation thereof
MX2017001619A (es) Encapsulacion de compuestos hidrofobicos biologicamente activos.
PH12018500905A1 (en) Aggregating microparticles for medical therapy
MX2016014320A (es) Composiciones de suspension de liberacion prolongada.
CA2934086C (en) Finisher composition comprising silicone microparticles and non-volatile oil
WO2015160641A3 (en) Compounds useful as immunomodulators
MX2018014399A (es) Particulas de nanoalumbre que contienen un agente de dimensionamiento.
MX2018000637A (es) Nanocápsula para la administración de un compuesto lipófilo y proceso de preparación de la misma.
HK1253288A1 (zh) 用於製備水性物質的球形膠囊的方法和通過所述方法獲得的膠囊
MX2017013665A (es) Composicion colorante dispersable en agua.
IL271852A (en) Solid powder supplements containing quercetin, a process for their preparation and their formulations
EP3104843A4 (en) Stabilized, sprayable emulsion containing active agent particles
EP3573747A4 (en) PREPARATION OF MICROPARTICLES OF AN ACTIVE SUBSTANCE
MX2021006070A (es) Formulaciones oculares para la administracion de farmacos y proteccion del segmento anterior del ojo.
IN2014CH01872A (es)
MX2016008527A (es) Preparaciones solidas que contienen tofogliflozina y proceso para producir las mismas.
EP3668991A4 (en) NANOCARRIERS FOR DELIVERY OF ACTIVE SUBSTANCES
PH12016501984A1 (en) Agrochemical formulation
SG10201902499VA (en) Therapeutic nanoparticles and related compositions, methods and systems
EP3615032A4 (en) FORMULATIONS, PROCEDURES, KITS AND DOSING FORMS FOR TREATMENT OF ATOPIC DERMATITIS AND IMPROVED STABILITY OF AN ACTIVE INGREDIENT
MX2017005700A (es) Composiciones de microesferas de gas encapsuladas en lipidos y metodos relacionados.
WO2016109400A3 (en) Lipid-encapsulated gas microsphere compositions and related methods
WO2016117883A8 (en) Pharmaceutical formulation comprising anti-egfr antibody
WO2014184660A3 (en) Emulsion stabilization